Ignalis-M 100/500 Tablet ER
Ignalis-M 100/500 Tablet ER
Sitagliptin (100mg) + Metformin (500mg)
Macsita-MXR 100/500 Tablet
Macleods Pharmaceuticals Pvt Ltd
Sitagliptin 100mg
Pack Size
1 units
Price
Save ₹29
that's 22% off!
About This Medicine
Product description & overview
Ignalis-M 100/500 Tablet ER
Ignalis-M 100/500 Tablet ER is a once-daily extended-release formulation of Sitagliptin (100mg) + Metformin (500mg), designed for the management of type 2 diabetes.
This combination effectively controls blood glucose levels by targeting two key mechanisms:
* Sitagliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin release and decreases glucagon secretion, contributing to improved glycemic control.
* Metformin: A biguanide with a multifaceted action, improving glucose uptake in the body's cells and reducing hepatic glucose production.
Ignalis-M 100/500 Tablet ER provides convenient, once-daily dosing without requiring multiple doses or adjustments throughout the day. This long-lasting formulation aids patients in maintaining consistent blood sugar levels for optimal glycemic control.
Important: This medication should only be used under the guidance of a healthcare professional. Always follow your doctor's instructions and consult with them before making any changes to your treatment regimen.
Active composition
Metformin 500 mg
+1 more active ingredient
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Sitagliptin
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Information regarding the use of Ignalis-M 100/500 Tablet ER during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Ignalis-M 100/500 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Ignalis-M 100/500 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Ignalis-M 100/500 Tablet ER may be needed. Please consult your doctor. Use of Ignalis-M 100/500 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Ignalis-M 100/500 Tablet ER is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Ignalis-M 100/500 Tablet ER